Acad. Sci. USA 72:1276-1280.
17. Johnson, R. M., D. W. Lancki, F. W. Fitch, and P. G. Spear.
1990. Herpes simplex virus glycoprotein D is recognized as
antigen by CD4+ and CD8+ T lymphocytes from infected mice.
Characterization of T cell clones. J. Immunol. 145:702-710.
18. Kahlon, J., and R. J. Whitley. 1988. Antibody response of the
newborn after herpes simplex virus infection. J. Infect. Dis.
158:925-933.
19. Kohl, S. 1985. Herpes simplex virus immunology: problems,
progress, and promises. J. Infect. Dis. 152:435-440.
19a.Kosz-Vnenchak, M., and D. Knipe. Unpublished data.
20. Kuhn, J. D., G. Dunkler, K. Munk, and R. W. Braun. 1987.
Analysis of the IgM and IgG antibody response against herpes
simplex virus type 1 (HSV-1) structural and nonstructural
proteins. J. Med. Virol. 23:135-150.
21. Lane, J. M., and J. D. Millar. 1971. Risks of small-pox vaccination complications in the United States. Am. J. Epidemiol.
92:238.
22. Lawman, M. J. P., B. T. Rouse, R. J. Courtney, and R. D.
Walker. 1980. Cell-mediated immunity against herpes simplex:
induction of cytotoxic T lymphocytes. Infect. Immun. 27:133-139.
23. Martin, S., R. J. Courtney, G. Fowler, and B. T. Rouse. 1988.
Herpes simplex virus type 1-specific cytotoxic T lymphocytes
recognize virus nonstructural proteins. J. Virol. 62:2265-2273.
24. Martin, S., B. Moss, P. W. Berman, L. A. Laskey, and B. T.
Rouse. 1987. Mechanisms of antiviral immunity induced by a
vaccinia virus recombinant expressing herpes simplex virus
type 1 glycoprotein D: cytotoxic T cells. J. Virol. 61:726-734.
25. Martin, S., X. Zhu, S. J. Silverstein, R. J. Courtney, F. Yao,
F. J. Jenkins, and B. T. Rouse. 1990. Murine cytotoxic T
lymphocytes specific for herpes simplex virus type 1 recognize
the immediate early protein ICP4 but not ICPO. J. Gen. Virol.
71:2391-2399.
26. McCarthy, A. M., L. McMahan, and P. A. Schaffer. 1989.
Herpes simplex type 1 ICP27 deletion mutants exhibit altered
patterns of transcription and are DNA deficient. J. Virol.
63:18-27.
27. McDermott, M. R., F. L. Graham, T. Hanke, and D. C. Johnson.
1989. Protection of mice against lethal challenge with herpes
simplex virus by vaccination with an adenovirus vector expressing HSV glycoprotein B. Virology 169:244-247.
28. McLaughlin-Taylor, E., D. E. Willey, E. M. Cantin, R. Eberle,
B. Moss, and H. Openshaw. 1988. A recombinant vaccinia virus
expressing herpes simplex virus type 1 glycoprotein B induces
cytotoxic T lymphocytes in mice. J. Gen. Virol. 69:1731-1734.
29. Meigner, G., R. Longnecker, and B. Roizman. 1988. In vivo
behavior of genetically engineered herpes simplex viruses
R7017 and R7020: construction and evaluation in rodents. J.
Infect. Dis. 3:603-614.
30. Murphy, B. R., and R. M. ChanocL 1990. Immunization against
viruses, p. 469-502. In B. N. Fields, D. M. Knipe, et al. (ed.),
Virology. Raven Press, New York.
30a.Nguyen, L. Unpublished data.
31. Paoletti, E., B. R. Lipinskas, C. Samsonoff, S. Mercer, and D.
Panicali. 1984. Construction of live vaccines using genetically
engineered poxviruses: biological activity of vaccinia virus
recombinants expressing the hepatitis B virus surface antigen
and the herpes simplex virus glycoprotein D. Proc. Natl. Acad.
Sci. USA 81:193-197.
32. Quinlan, M. P., L. B. Chen, and D. M. Knipe. 1984. The
intranuclear location of a herpes simplex virus DNA-binding
protein is determined by the status of viral DNA replication.
Cell 36:857-868.
33. Quinlan, M. P., and D. M. Knipe. 1985. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral
functions. Mol. Cell. Biol. 5:957-963.
34. Redelman, D., S. Nichol, R. Kliefort, M. Van Der Maaten, and
C. Whetstone. 1989. Experimental vesicular stomatitis virus
infection of swine: extent of infection and immunological re- sponse. Vet. Immunol. Immunopathol. 20(4):345-361.
35. Rice, S. A., and D. A. Knipe. 1990. Genetic evidence for two
distinct transactivation functions of the herpes simplex virus a
